Synthesis, Characterization, and Biological Activity of Novel 1,2,4-triazole Moieties: Antileishmania, Antimicrobial Effects, and Molecular Docking Studies

Nevin Süleymanoğlu,Yasemin Ünver,Reşat Ustabaş,Fatih Çelik,Halil İbrahim Güler,Şahin Direkel,Kadriye İnan Bektaş
DOI: https://doi.org/10.1016/j.molstruc.2024.138724
IF: 3.841
2024-05-24
Journal of Molecular Structure
Abstract:In this study; new 1,2,4-triazole derivatives, (E)-4-(((3-methyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)imino)methyl)phenyl 4-methoxybenzoate (3a), (E)-4-(((3-benzyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)imino)methyl)phenyl 4-methoxybenzoate (3b) and (E)-4-(((3-(4-fluorobenzyl)-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)imino)methyl)phenyl 4-methoxy benzoate methoxy benzoate (3c) were synthesized and characterized by FTIR and NMR ( 1 H- and 13 C-) spectroscopic methods. Structural and spectral parameters were calculated by DFT/B3LYP/6-311++G(d,p) methods. The newly synthesized compounds 3a-3c were evaluated for their antimicrobial activities against eight pathogenic microorganisms. Standard commercial drugs ampicillin and fluconazole were used as references for bacteria and yeast, respectively. The leishmanicidal activity of three different synthesized compounds against Leishmania infantum promastigotes was investigated using the microdilution method. In addition, the study attempted to investigate the interactions crucial for the antileishmanial activity of compound 3b by molecular docking analysis targeting trypanothione reductase (TRe).
chemistry, physical
What problem does this paper attempt to address?